Fintel reports that on April 6, 2025, CIBC CAPITAL MARKETS downgraded their outlook for Bank of Montreal (NYSE:BMO) from Outperform to Neutral. Analyst Price Forecast Suggests 23.73% Upside As of ...

The mounting uncertainty has now prompted BMO Capital Markets to lower its year-end target for the benchmark index. “We are revising our 2025 year-end S&P 500 price targets down to 6,100 from 6,700.

Investing.com -- BMO Capital Markets downgraded Novo Nordisk (NYSE:NVO) to “Market Perform” from “Outperform” and cut its price target to $64, saying the Danish drugmaker’s early lead in ...